home / stock / vtgn / vtgn quote
Last: | $3.31 |
---|---|
Change Percent: | 0.0% |
Open: | $3.34 |
Close: | $3.31 |
High: | $3.455 |
Low: | $3.3 |
Volume: | 20,071 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.31 | $3.34 | $3.31 | $3.455 | $3.3 | 20,071 | 07-04-2024 |
$3.31 | $3.34 | $3.31 | $3.455 | $3.3 | 19,935 | 07-03-2024 |
$3.33 | $3.55 | $3.33 | $3.59 | $3.32 | 72,394 | 07-02-2024 |
$3.57 | $3.49 | $3.57 | $3.66 | $3.49 | 74,851 | 07-01-2024 |
$3.48 | $3.51 | $3.48 | $3.54 | $3.4 | 171,410 | 06-28-2024 |
$3.48 | $3.28 | $3.48 | $3.53 | $3.22 | 107,761 | 06-27-2024 |
$3.25 | $3.3 | $3.25 | $3.32 | $3.22 | 52,108 | 06-26-2024 |
$3.32 | $3.23 | $3.32 | $3.39 | $3.23 | 83,567 | 06-25-2024 |
$3.23 | $3.35 | $3.23 | $3.48 | $3.18 | 92,750 | 06-24-2024 |
$3.35 | $3.21 | $3.35 | $3.37 | $3.151 | 118,845 | 06-21-2024 |
$3.22 | $3.33 | $3.22 | $3.33 | $3.2 | 84,478 | 06-20-2024 |
$3.31 | $3.47 | $3.31 | $3.4899 | $3.26 | 146,935 | 06-19-2024 |
$3.31 | $3.47 | $3.31 | $3.4899 | $3.26 | 146,935 | 06-18-2024 |
$3.42 | $3.45 | $3.42 | $3.49 | $3.31 | 154,706 | 06-17-2024 |
$3.52 | $3.5 | $3.52 | $3.5465 | $3.37 | 307,332 | 06-14-2024 |
$3.52 | $3.51 | $3.52 | $3.7 | $3.51 | 150,245 | 06-13-2024 |
$3.69 | $3.8 | $3.69 | $3.98 | $3.66 | 100,994 | 06-12-2024 |
$3.77 | $3.69 | $3.77 | $3.78 | $3.61 | 134,820 | 06-11-2024 |
$3.68 | $3.79 | $3.68 | $3.8 | $3.54 | 200,031 | 06-10-2024 |
$3.79 | $3.8 | $3.79 | $3.86 | $3.76 | 169,713 | 06-07-2024 |
News, Short Squeeze, Breakout and More Instantly...
VistaGen Therapeutics Inc. Company Name:
VTGN Stock Symbol:
NASDAQ Market:
VistaGen Therapeutics Inc. Website:
Vistagen (NASDAQ: VTGN) , a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced that it has been recognized by Mental Health America (“MHA”) for its dedication to pr...
Mental Health America’s highest national certification enhances Vistagen’s ongoing efforts to promote mental health throughout the U.S. Vistagen (Nasdaq: VTGN), a clinical-stage neuroscience-focused biopharmaceutical company dedicated to the development and commercialization...